JPMORGAN CHASE & CO - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 14 filers reported holding CARDLYTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2022$517,000
-18.7%
800,0000.0%0.00%
Q2 2022$636,000
+15.8%
800,000
+60.0%
0.00%
Q4 2021$549,000
-87.6%
500,000
-85.7%
0.00%
-100.0%
Q3 2021$4,436,0003,500,0000.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
GUARDIAN POINT CAPITAL, LP 5,000,000$5,149,0001.88%
LINDEN ADVISORS LP 65,612,000$66,940,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 38,478,000$39,110,0000.38%
Teton Advisors, Inc. 1,030,000$1,061,0000.18%
683 Capital Management, LLC 2,000,000$2,040,0000.11%
Nicholas Investment Partners, LP 1,385,000$1,401,0000.10%
GABELLI FUNDS LLC 6,920,000$7,128,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 10,000,000$10,165,0000.03%
Citadel Advisors 98,500,000$100,325,0000.02%
GAMCO INVESTORS, INC. ET AL 300,000$309,0000.00%
View complete list of CARDLYTICS INC shareholders